We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Agilent Technologies | NYSE:A | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.11 | -0.07% | 153.97 | 154.84 | 152.50 | 152.57 | 453,739 | 18:25:16 |
Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Jefferies Virtual Healthcare Conference on June 1. Details are included below:
Jefferies Virtual Healthcare Conference Tuesday, June 1, 2021 at 2:00 p.m. (ET) Presenting for Agilent: Bob McMahon, Agilent chief financial officer
Links to join the webcast will be available in the "News & Events -- Events" portion of the Investor Relations section of the Agilent website.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005918/en/
Investor Contact: Ruben DiRado +1 408 345 8971 ruben_dirado@agilent.com
Media Contact: Tom Beermann +1 408 553 2914 tom.beermann@agilent.com
1 Year Agilent Technologies Chart |
1 Month Agilent Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions